Insider · CIK 0001493187
Laurel J Krzeminski
director
Files at LMB (Limbach Holdings, Inc.). First filing Sep 16, 2026, latest Sep 16, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$25k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LMB: Limbach Holdings, Inc.
LMBOct 9, 2026 · close 51.26
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | LMB Limbach Holdings, Inc. | POpen-market purchase Common Stockindirect: By SEP-IRA | +500 | $50.58 | $25k | 4,000 | 26 d ago |
| Jan 1, 2026 | LMB Limbach Holdings, Inc. | MOption exercise Common Stock | +956 | $0.00 | $0 | 36,452 | Jan 5, 2026 |
| Jan 1, 2026 | LMB Limbach Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -956 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Jan 1, 2026 | LMB Limbach Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +1,498 | $0.00 | $0 | 1,498 | Jan 5, 2026 |
| Jan 1, 2025 | LMB Limbach Holdings, Inc. | MOption exercise Common Stock | +1,914 | $0.00 | $0 | 35,496 | Jan 3, 2025 |
| Jan 1, 2025 | LMB Limbach Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,914 | $0.00 | $0 | 0 | Jan 3, 2025 |
| Jan 1, 2025 | LMB Limbach Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +956 | $0.00 | $0 | 956 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.